Article

Substrate specificity of HMRZ-86 for beta-lactamases, including extended-spectrum beta-lactamases (ESBLs).

Research Center for Anti-Infective Drugs, Kitasato Institute, Minato-ku, Tokyo, Japan.
Journal of Infection and Chemotherapy (impact factor: 1.8). 01/2008; 13(6):390-5. DOI:10.1007/s10156-007-0563-2 pp.390-5
Source: PubMed

ABSTRACT HMRZ-86 was designed as a new chromogenic cephalosporin to detect extended-spectrum beta-lactamases (ESBLs) and similar evolved beta-lactamases, such as metallo-beta-lactamases, derepressed AmpC, and extended oxacillinase. We report here our investigation of the kinetic parameters of several types of beta-lactamases to show the enzymatic characteristics of HMRZ-86. The Michaelis constant (Km values of HMRZ-86 for ESBLs were twice to three and half times as high as those of nitrocefin, and the maximum velocity (Vmax) was one-fifth that of nitrocefin. The Km and Vmax of HMRZ-86 for AmpC were both smaller than those of nitrocefin. The kinetic parameters of HMRZ-86 for metallo beta-lactamase (MBL) were very variable, depending on the type of buffer solution used and the concentration of zinc ions. For MBL, the Km values of HMRZ-86 were higher than those of nitrocefin, but the Vmax values were almost the same as those of nitrocefin. Although the chemical structure of HMRZ-86 is similar to that of nitrocefin, we think the enzymatic reactivities of the two entities for beta-lactamases are very different.

0 0
 · 
0 Bookmarks
 · 
36 Views

Keywords

AmpC
 
beta-lactamases
 
buffer solution
 
chemical structure
 
derepressed AmpC
 
enzymatic characteristics
 
enzymatic reactivities
 
ESBLs
 
extended-spectrum beta-lactamases
 
kinetic parameters
 
Km values
 
maximum velocity
 
MBL
 
metallo beta-lactamase
 
metallo-beta-lactamases
 
Michaelis constant
 
new chromogenic cephalosporin
 
smaller
 
two entities